The grueling correction has certainly taken a heavy toll on the market for new stocks. Consider that there were no offerings in January, which has not happened since 2011 (this is when the European crisis was in full force and spooked markets). Yet, this week should see things get back into action as there are five new stocks to watch.
Although, investors are likely to demand dirt-cheap valuations. After all, four the new stocks are in the high-risk biotech category. And yes, the performance of this sector has been horrific, with the iShares Nasdaq Biotechnology Index (IBB) already off 21% during the year.
OK, so what are the new stocks to watch this week? Well, let’s take a look at each: Read